Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lombardi, C
Right arrow Articles by Donato, F
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lombardi, C
Right arrow Articles by Donato, F

Chest, Vol 97, 639-644, Copyright © 1990 by American College of Chest Physicians

ARTICLES

Clinical significance of a multiple biomarker assay in patients with lung cancer. A study with logistic regression analysis

C Lombardi, GF Tassi, G Pizzocolo and F Donato
Department of Internal Medicine, S. Orsola Hospital, Brescia, Italy.

The relative usefulness of a combination of some tumor markers, such as CEA, AFP, ferritin and NSE for the diagnosis of lung cancer was assessed by multiple logistic analysis. Serum concentration of these markers was determined in 68 patients with lung cancer (50 with NSCLC and 18 with SCLC, in 68 patients with benign lung disease and 75 normal control subjects. Ferritin proved to be the most useful in diagnosing both NSCLC and SCLC, while NSE was found to be of some help in diagnosing SCLC only. The multiple marker panel proved to be more sensitive and specific than any single marker in discriminating lung cancer from normal control tissue, but it was of limited value in discriminating malignant from benign lung disease. The results of the present study would suggest that the panel of investigated tumor markers is not of great help for the early diagnosis of lung cancer.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Zhong, G. E. Hidalgo, A. J. Stromberg, N. H. Khattar, J. R. Jett, and E. A. Hirschowitz
Using Protein Microarray as a Diagnostic Assay for Non-Small Cell Lung Cancer
Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1308 - 1314.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Paone, E. Nicastri, G. Lucantoni, R. Dello Iacono, P. Battistoni, A. L. D'Angeli, and G. Galluccio
Endobronchial Ultrasound-Driven Biopsy in the Diagnosis of Peripheral Lung Lesions
Chest, November 1, 2005; 128(5): 3551 - 3557.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American College of Chest Physicians.